Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences
28 Février 2024 - 12:30PM
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company
developing precision genetic medicines through base editing, today
announced that management will participate in the following
upcoming investor conferences:
- TD Cowen 44th Annual Health Care Conference, emerging genetic
therapy approaches corporate panel discussion on Wednesday, March
6, 2024 at 12:50 p.m. ET
- Leerink Partners Global Biopharma Conference, fireside chat on
Monday, March 11, 2024 at 2:40 p.m. ET
- Barclays Global Healthcare Conference, fireside chat on
Wednesday, March 13, 2024 at 2:35 p.m. ET
The live conference webcasts will be available in the investor
section of the company's website at www.beamtx.com and will be
archived for 60 days following the presentation.
About Beam TherapeuticsBeam Therapeutics
(Nasdaq: BEAM) is a biotechnology company committed to establishing
the leading, fully integrated platform for precision genetic
medicines. To achieve this vision, Beam has assembled a platform
that includes a suite of gene editing and delivery technologies and
is in the process of building internal manufacturing capabilities.
Beam’s suite of gene editing technologies is anchored by base
editing, a proprietary technology that is designed to enable
precise, predictable and efficient single base changes, at targeted
genomic sequences, without making double-stranded breaks in the
DNA. This has the potential to enable a wide range of potential
therapeutic editing strategies that Beam is using to advance a
diversified portfolio of base editing programs. Beam is a
values-driven organization committed to its people, cutting-edge
science, and a vision of providing life-long cures to patients
suffering from serious diseases.
Contacts:
Investors:Holly ManningTHRUST Strategic
Communicationsholly@thrustsc.com
Media:Dan Budwick1ABdan@1abmedia.com
Beam Therapeutics (NASDAQ:BEAM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Beam Therapeutics (NASDAQ:BEAM)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024